-

City of Hope Recognized for the Fourth Consecutive Year as a ‘Top Hospital and Health System’ for Diversity, Equity and Inclusion

Fair360 ranked the national cancer organization No. 2, maintaining its position from 2023

LOS ANGELES--(BUSINESS WIRE)--City of Hope, one of the largest cancer research and treatment organizations in the United States, has once again been recognized by Fair360 (formerly DiversityInc) as one of the “Top Hospitals and Health Systems” in the country for diversity, equity and inclusion (DEI), ranking second on a list of 20 reputable health care organizations for the second year in a row. As the top National Cancer Institute-designated comprehensive cancer center, City of Hope is holding strong in the specialty ranking’s top 10 for the fourth consecutive year.

The Fair360 survey evaluates companies based on six key areas of workplace fairness, providing a trusted measure of transparency, equitable outcomes for employees and the effectiveness of fairness strategies and practices. The “Top Hospitals and Health Systems” list is industry-specific and based on a data-driven evaluation.

“This achievement underscores our institutional commitment to inclusion, collaboration and health equity, which helps us provide compassionate and culturally competent care that meets the needs of all communities. It also cultivates an inclusive environment where our patients and employees feel valued and heard,” said Angela L. Talton, senior vice president and system chief diversity, equity and inclusion officer.

The consecutive ranking is particularly meaningful as inclusivity and health equity are in the DNA of City of Hope, which is constantly striving to benefit its communities by decreasing health disparities in multiple ways. Efforts include co-authoring systemwide DEI training with minority business enterprise training vendors, organizing thoughtful community collaborations and addressing root causes of barriers to good health.

Internally, diversity, equity and inclusion remain at the heart of City of Hope’s initiatives and communications. Staff embarked on a “Situational Inclusivity Learning Journey,” complete with interactive modules and online classes to lay the groundwork for an inclusive culture based upon changing actions and behaviors to be more consciously inclusive. Notably, City of Hope’s holistic approach to recruitment and hiring also earned recognition as one of the “Top Companies for Talent Acquisition for Women of Color” by Fair360, a distinction earned through rigorous evaluation of new hire metrics, human capital management, inclusive onboarding practices, diverse candidate slate requirements and comprehensive employee benefits.

City of Hope’s national system of provider and research entities now serves approximately 144,000 patients each year, with more than 12,000 team members, 550 physicians and more than 1,000 scientists and researchers across a network of locations in California, Arizona, Illinois and Georgia.

About City of Hope

City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training and innovation initiatives. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.

Contacts

Jessica Weeks
Jessica.Weeks@coh.org

City of Hope


Release Versions

Contacts

Jessica Weeks
Jessica.Weeks@coh.org

More News From City of Hope

Leukemia Survivors to Meet Their Lifesaving Stem Cell Donors at City of Hope’s Annual Bone Marrow Transplant (BMT) Reunion, Celebrating Program’s 50-Year Milestone

LOS ANGELES--(BUSINESS WIRE)--At an age when most teenagers are focused on school, sports and the future, Los Angeles teenager Vaughn Wilson was fighting for his life. Diagnosed with leukemia just days after Christmas in 2022, the then‑15‑year‑old would soon rely on a bone marrow transplant — and the generosity of a donor he had never met — to survive. On May 1, Wilson, now 18, will meet his German donor for the first time at City of Hope’s BMT Reunion in Duarte – an event that coincides with a...

City of Hope and UC Berkeley Researchers Teach AI to Spot Cancer Risk by Squeezing Individual Breast Cells

LOS ANGELES--(BUSINESS WIRE)--Researchers at City of Hope®, a cancer research and treatment organization, and the University of California, Berkeley, have created a novel microfluidic platform that can assess women’s breast cancer risk at the cellular level. The first-of-its-kind platform squeezes individual breast epithelial cells, creating a taxing environment to measure how they deform, recover and behave under stress, according to a new study published today in Lancet’s eBioMedicine. Becaus...

City of Hope Scientists to Share New Findings on Cancer Risk, Immune Resistance and AI‑Driven Discovery at AACR 2026

LOS ANGELES--(BUSINESS WIRE)--Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, will present new data at the AACR Annual Meeting 2026, sharing insights into cancer risk, treatment resistance and emerging therapeutic strategies across solid and blood cancers. From April 17–22, expertise from City of Hope...
Back to Newsroom